메뉴 건너뛰기
Annals of Neurology
Volumn 64, Issue 1, 2008, Pages 110-
Reply
Author keywords

[No Author keywords available]
Indexed keywords

BETA INTERFERON;
EID: 48949084991     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21372     Document Type: Letter
Times cited : (2)
References (4)
  • 1
    • 34247608145 scopus 로고    scopus 로고
    • New natural history of interferon-beta-treated relapsing multiple sclerosis
    • Trojano M, Pellegrini F, Fuiani A, et al. New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol 2007;61:300-306.
    • (2007) Ann Neurol , vol.61 , pp. 300-306
    • Trojano, M.1    Pellegrini, F.2    Fuiani, A.3
  • 2
    • 33947227921 scopus 로고    scopus 로고
    • Immortal time bias in observational studies of drug effects
    • Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007;16:241-249.
    • (2007) Pharmacoepidemiol Drug Saf , vol.16 , pp. 241-249
    • Suissa, S.1
  • 3
    • 27744473507 scopus 로고    scopus 로고
    • Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: A comparison of methods
    • Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol 2005;162:1016-1023.
    • (2005) Am J Epidemiol , vol.162 , pp. 1016-1023
    • Zhou, Z.1    Rahme, E.2    Abrahamowicz, M.3    Pilote, L.4
  • 4
    • 2542594646 scopus 로고    scopus 로고
    • A potential bias in safety evaluation during open-label extensions of randomized clinical trials
    • Rothman KJ. A potential bias in safety evaluation during open-label extensions of randomized clinical trials. Pharmacoepidemiol Drug Saf 2004;13:295-298.
    • (2004) Pharmacoepidemiol Drug Saf , vol.13 , pp. 295-298
    • Rothman, K.J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.